These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3278713)
1. Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Zhang Y; König I; Schirmer RH Biochem Pharmacol; 1988 Mar; 37(5):861-5. PubMed ID: 3278713 [TBL] [Abstract][Full Text] [Related]
2. Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Zhang YA; Hempelmann E; Schirmer RH Biochem Pharmacol; 1988 Mar; 37(5):855-60. PubMed ID: 3278712 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. Karplus PA; Krauth-Siegel RL; Schirmer RH; Schulz GE Eur J Biochem; 1988 Jan; 171(1-2):193-8. PubMed ID: 3338461 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea). Shinohara K; Tanaka KR Clin Chim Acta; 1979 Mar; 92(2):147-52. PubMed ID: 39688 [TBL] [Abstract][Full Text] [Related]
5. Consequences of erythrocytic glutathione reductase deficiency. Frischer H; Ahmad T J Lab Clin Med; 1987 May; 109(5):583-8. PubMed ID: 3572207 [TBL] [Abstract][Full Text] [Related]
6. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea]. Frischer H; Ahmad T J Lab Clin Med; 1977 May; 89(5):1080-91. PubMed ID: 870569 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cohen MB; Duvel DL Biochem Pharmacol; 1988 Sep; 37(17):3317-20. PubMed ID: 3401259 [TBL] [Abstract][Full Text] [Related]
8. [Effect of BCNU on glutathione metabolism in human blood cells]. Benöhr HC; Waller HD Klin Wochenschr; 1979 Aug; 57(16):845-50. PubMed ID: 502351 [TBL] [Abstract][Full Text] [Related]
9. [Glutathionestatus of Plasmodium vinckei parasitized erythrocytes in correlation to the intraerythrocytic development of the parasite (author's transl)]. Picard-Maureau A; Hempelmann E; Krämmer G; Jackisch R; Jung A Tropenmed Parasitol; 1975 Dec; 26(4):405-16. PubMed ID: 1216329 [TBL] [Abstract][Full Text] [Related]
10. Pathways for the reduction of oxidized glutathione in the Plasmodium falciparum-infected erythrocyte: can parasite enzymes replace host red cell glucose-6-phosphate dehydrogenase? Roth EF; Schulman S; Vanderberg J; Olson J Blood; 1986 Mar; 67(3):827-30. PubMed ID: 3511989 [TBL] [Abstract][Full Text] [Related]
11. Malarial parasite hexokinase and hexokinase-dependent glutathione reduction in the Plasmodium falciparum-infected human erythrocyte. Roth EF J Biol Chem; 1987 Nov; 262(32):15678-82. PubMed ID: 3316204 [TBL] [Abstract][Full Text] [Related]
12. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Meierjohann S; Walter RD; Müller S Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291 [TBL] [Abstract][Full Text] [Related]
13. Influence of glutathione on the mutagenicity of 2-chloroethylnitrosoureas. Mutagenic potential of glutathione derivatives formed from 2-chloroethylnitrosoureas and glutathione. Stahl W; Denkel E; Eisenbrand G Mutat Res; 1988 Dec; 206(4):459-65. PubMed ID: 3060720 [TBL] [Abstract][Full Text] [Related]
14. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas. Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes. Miller J; Golenser J; Spira DT; Kosower NS Exp Parasitol; 1984 Jun; 57(3):239-47. PubMed ID: 6373352 [TBL] [Abstract][Full Text] [Related]
16. Glutathione reductase and glutamate dehydrogenase of Plasmodium falciparum, the causative agent of tropical malaria. Krauth-Siegel RL; Müller JG; Lottspeich F; Schirmer RH Eur J Biochem; 1996 Jan; 235(1-2):345-50. PubMed ID: 8631352 [TBL] [Abstract][Full Text] [Related]
17. Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study. Gallo V; Schwarzer E; Rahlfs S; Schirmer RH; van Zwieten R; Roos D; Arese P; Becker K PLoS One; 2009 Oct; 4(10):e7303. PubMed ID: 19806191 [TBL] [Abstract][Full Text] [Related]
18. Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Luzzatto L; Usanga FA; Reddy S Science; 1969 May; 164(3881):839-42. PubMed ID: 4889647 [TBL] [Abstract][Full Text] [Related]
19. Studies on glutathione reductase and methemoglobin from human erythrocytes parasitized with Plasmodium falciparum. Hempelmann E; Schirmer RH; Fritsch G; Hundt E; Gröschel-Stewart U Mol Biochem Parasitol; 1987 Feb; 23(1):19-24. PubMed ID: 3553936 [TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU. Rice KP; Penketh PG; Shyam K; Sartorelli AC Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]